[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU5543494A - Method and kit for cancer diagnosis - Google Patents

Method and kit for cancer diagnosis

Info

Publication number
AU5543494A
AU5543494A AU55434/94A AU5543494A AU5543494A AU 5543494 A AU5543494 A AU 5543494A AU 55434/94 A AU55434/94 A AU 55434/94A AU 5543494 A AU5543494 A AU 5543494A AU 5543494 A AU5543494 A AU 5543494A
Authority
AU
Australia
Prior art keywords
kit
cancer diagnosis
diagnosis
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55434/94A
Inventor
Varda Rotter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of AU5543494A publication Critical patent/AU5543494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU55434/94A 1992-10-30 1993-10-29 Method and kit for cancer diagnosis Abandoned AU5543494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL103600 1992-10-30
IL103600A IL103600A0 (en) 1992-10-30 1992-10-30 Method and kit for cancer diagnosis
PCT/US1993/010411 WO1994010575A1 (en) 1992-10-30 1993-10-29 Method and kit for cancer diagnosis

Publications (1)

Publication Number Publication Date
AU5543494A true AU5543494A (en) 1994-05-24

Family

ID=11064167

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55434/94A Abandoned AU5543494A (en) 1992-10-30 1993-10-29 Method and kit for cancer diagnosis

Country Status (3)

Country Link
AU (1) AU5543494A (en)
IL (1) IL103600A0 (en)
WO (1) WO1994010575A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444969C1 (en) * 1994-12-16 1996-10-24 Orga Med Dr Med Erwin Klopfer Detection of antibodies against p53 in body fluids
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
WO2000073479A1 (en) * 1999-05-28 2000-12-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
CN1300580C (en) * 2004-12-31 2007-02-14 中国人民解放军第306医院 Mass spectrum model for detecting liver cancer serum characteristic protein and method for preparation
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples

Also Published As

Publication number Publication date
IL103600A0 (en) 1993-03-15
WO1994010575A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
AU1075695A (en) Method for diagnosing cancer
AU5921196A (en) Composition and method for tumor imaging
AU5268696A (en) Novel compounds and methods for therapy
AU4670293A (en) Non-invasive testing
AU4861493A (en) Clear leave-on treatment composition and method
AU4609093A (en) Method and kit for detecting explosives
AU3628795A (en) Accelerator-base methods and apparatus for measurement-while-drilling
AU4798093A (en) Methods and apparatus for mri
AU2035195A (en) Electroheating apparatus and methods
AU5975694A (en) Electrotherapeutic apparatus
HU9400710D0 (en) 2-debenzoyl-2-acyl-taxol derivatives and methods for making same
AU4139196A (en) Method and composition for antiviral therapy
AU4529393A (en) Method and kit for testing tumors for drug sensitivity
AU6400294A (en) Tripterinin compound and method
AU626161B2 (en) Image reduction method
AU4930993A (en) Coupled replication-translation methods and kits for protein synthesis
AU5543494A (en) Method and kit for cancer diagnosis
AU3776493A (en) Method and diagnostic kit for determination of bacteria
AU4489693A (en) Apparatus and methods for improved construction
AU6343896A (en) Zinc(ii) complexes and methods related thereto
AU4059795A (en) Normalization method
AU1480497A (en) Cancer treatment
AU3385693A (en) Determination method
AU5737494A (en) Human thrombospondin-4
AU3177893A (en) Method for diagnosing and treating cancer